Jesse Zuckerman

Jesse Zuckerman

Auto-generated profile, based on publicly available information

Jesse Zuckerman

Division of Colon and Rectal Surgery, Cedars-Sinai Medical Center, Los Angeles, California

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
LDL.M. Drudi
L.M. Drudi
KPK. Phung
K. Phung
MAM. Ades
M. Ades
JZJ. Zuckerman
J. Zuckerman
LML. Mullie
L. Mullie
JAJ. Afilalo
J. Afilalo

1 September 2021 in Surgery
Verified
Journal Article
Closed access
JZJesse Zuckerman
Jesse Zuckerman
NCNatalie Coburn
Natalie Coburn
JCJeannie Callum
Jeannie Callum
AMAlyson L. Mahar
Alyson L. Mahar
SASergio A. Acuña
Sergio A. Acuña
JHJulie Hallet
Julie Hallet

25 February 2020 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JZJesse Zuckerman
Jesse Zuckerman
RGRichard Garfinkle
Richard Garfinkle
CVCarol‐Ann Vasilevksy
Carol‐Ann Vasilevksy
GGGabriela Ghitulescu
Gabriela Ghitulescu
JFJulio Faria
Julio Faria
MBMarylise Boutros
Marylise Boutros

25 April 2023 in Critical Care
Verified
Journal Article
Open access
PDF file
BTBourke W. Tillmann
Bourke W. Tillmann
JHJulie Hallet
Julie Hallet
RSRinku Sutradhar
Rinku Sutradhar
MGMatthew P. Guttman
Matthew P. Guttman
NCNatalie Coburn
Natalie Coburn
PGPietro Galuzzo
Pietro Galuzzo
Background: Older adults are at high-risk for a post-operative intensive care unit (ICU) admission, yet little is known about the impact of these admissions on quality of life. The objective of this study was to evaluate the impact of an unexpected post-operative ICU admission on the burden of cancer symptoms among older adults who underwent high-intensity cancer surgery and survived to hospital discharge. Methods: We performed a population-based cohort study of older adults (age ≥ 70) who underwent high-intensity cancer surgery and survived to hospital discharge in Ontario, Canada (2007–2017). Using the Edmonton Symptom Assessment System (ESAS), a standardized tool that quantifies patient-reported physical, mental, and emotional symptoms, we described the burden of cancer symptoms during the year after surgery. Total symptom scores ≥ 40 indicated a moderate-to-severe symptom burden. Modified log-Poisson analysis was used to estimate the impact of an unexpected post-operative ICU admission (admission not related to routine monitoring) on the likelihood of experiencing a moderate-to-severe symptom burden during the year after surgery, accounting for potential confounders. We then used multivariable generalized linear mixed models to model symptom trajectories among patients with two or more ESAS assessments. A 10-point difference in total symptom scores was considered clinically significant. Results: Among 16,560 patients (mean age 76.5 years; 43.4% female), 1,503 (9.1%) had an unexpected ICU admission. After accounting for baseline characteristics, patients with an unexcepted ICU admission were more likely to experience a moderate-to-severe symptom burden relative to those without an unexpected ICU admission (RR 1.64, 95% CI 1.31–2.05). Specifically, among patients with an unexcepted ICU admission the average probability of experiencing moderate-to-severe symptoms ranged from 6.9% (95 CI 5.8–8.3%) during the first month after surgery to 3.2% (95% CI 0.9–11.7%) at the end of the year. Among the 11,229 (67.8%) patients with multiple ESAS assessments, adjusted differences in total scores between patients with and without an unexpected ICU admission ranged from 2.0 to 5.7-points throughout the year (p < 0.001). Conclusion: While unexpected ICU admissions are associated with a small increase in the likelihood of experiencing a moderate-to-severe symptom burden, most patients do not experience a high overall symptom burden during the year after surgery. These findings support the role of aggressive therapy among older adults after major surgery.

23 July 2025 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
JZJesse Zuckerman
Jesse Zuckerman
AOAnthony de Buck van Overstraeten
Anthony de Buck van Overstraeten
GMGil Y. Melmed
Gil Y. Melmed
WMWilliam Conan Mustain
William Conan Mustain
JSJeffrey S. Scow
Jeffrey S. Scow
KZKaren Zaghiyan
Karen Zaghiyan
BACKGROUND: IPAA is the standard procedure for patients with ulcerative colitis or unclassified IBD seeking intestinal continuity after proctocolectomy. Previous studies on function are limited by retrospective design, single-center scope, and insufficient functional domain data. OBJECTIVE: To provide prospective, multicenter data on functional outcomes after IPAA. DESIGN: Prospective cohort study. SETTINGS: Several North American centers. PATIENTS: Adults scheduled for IPAA between June 2018 and June 2022. MAIN OUTCOME MEASURES: Patient-reported colorectal (Colorectal Functional Outcome, Wexner Fecal Incontinence Score), sexual (Patient-Reported Outcomes Measurement Information System Sexual Function and Satisfaction), urinary (International Prostate Symptom Score), and global (Patient-Reported Outcomes Measurement Information System Global-10) function were the main outcome measures. RESULTS: A total of 203 patients were included (mean age, 35.8 ± 13.4, 59% men). Most had ulcerative colitis (95%), with refractory disease the most common surgical indication (91%). Fifty-seven patients (28%) had a subtotal colectomy without IPAA. Bowel function improved significantly after IPAA (Colorectal Functional Outcome mean, 50.6 ± 18.8 at baseline to 24.3 ± 17.7 at 12 months, p < 0.0001; Wexner mean 8.2 ± 5.3 at baseline to 4.3 ± 4.5 at 12 months, p < 0.0001), as did global health satisfaction (mental health mean T-score 41.5 ± 10.8 at baseline to 51.2 ± 10.3 at 12 months, p < 0.0001; physical health mean T-score 39.2 ± 9.2 at baseline to 52.2 ± 9.2 at 12 months, p < 0.0001). Sexual interest increased for both women (mean T-score, 34.2 ± 13.2 at baseline to 41.9 ± 13.0 at 12 months, p = 0.007) and men (mean T-score, 39.4 ± 13.8 at baseline to 51.1 ± 9.6 at 12 months, p < 0.0001); other sexual domains were stable. Urinary function remained stable (mean, 7.2 ± 6.3 at baseline to 5.4 ± 6.3 at 12 months, p = 0.08). Surgical indication was significantly associated with postoperative bowel function ( p = 0.0003). LIMITATIONS: Sample size is limited; follow-up is limited to 12 months. CONCLUSION: In this prospective multicenter cohort, IPAA led to significant improvements in bowel function, continence, sexual interest, and overall health, with no decline in urinary or sexual functions. These findings support the role of IPAA in restoring function and inform preoperative counseling and decision-making. See Video Abstract . MEJORA EN LOS RESULTADOS FUNCIONALES TRAS LA ANASTOMOSIS ILEOANAL: RESULTADOS DEL ESTUDIO ESTADOUNIDENSE SOBRE LA ANASTOMOSIS ILEOANAL: ANTECEDENTES: La anastomosis ileoanal es el procedimiento estándar para pacientes con colitis ulcerosa o enfermedad inflamatoria intestinal no clasificada que buscan continuidad intestinal tras una proctocolectomía. Los estudios previos sobre la función están limitados por su diseño retrospectivo, su alcance unicéntrico y la insuficiencia de datos sobre el dominio funcional. OBJETIVO: Proporcionar datos prospectivos y multicéntricos sobre los resultados funcionales tras la anastomosis ileoanal. DISEÑO: Estudio prospectivo de cohortes. ENTORNOS: Varios centros norteamericanos. PACIENTES: Adultos programados para someterse a una anastomosis ileoanal entre junio de 2018 y junio de 2022. PPRINCIPALES MEDIDAS DE RESULTADO: Función colorrectal (COREFO, Wexner Fecal Incontinence Score), sexual (PROMIS Sex-FS), urinaria (International Prostate Symptom Score) y global (PROMIS Global-10) comunicada por los pacientes. RESULTADOS: Se incluyó un total de 203 pacientes (edad media, 35,8 ± 13,4; 59 % hombres). La mayoría padecía CU (95 %) con enfermedad refractaria como indicación quirúrgica más frecuente (91 %). Cincuenta y siete pacientes (28 %) se sometieron a una colectomía subtotal sin anastomosis ileoanal. La función intestinal mejoró significativamente tras la anastomosis ileoanal (media COREFO, 50,6 ± 18,8 al inicio del estudio frente a 24,3 ± 17,7 a los 12 meses, p < 0,0001; media de Wexner 8,2 ± 5,3 al inicio del estudio y 4,3 ± 4,5 a los 12 meses, p < 0,0001), al igual que la satisfacción global con la salud (media de la puntuación T de salud mental 41,5 ± 10,8 al inicio del estudio y 51,2 ± 10,3 a los 12 meses, p < 0,0001; puntuación T media de salud física de 39,2 ± 9,2 al inicio del estudio a 52,2 ± 9,2 a los 12 meses, p < 0,0001). El interés sexual aumentó tanto en las mujeres (puntuación T media de 34,2 ± 13,2 al inicio del estudio a 41,9 ± 13,0 a los 12 meses, p = 0,007) y en los hombres (puntuación T media, 39,4 ± 13,8 al inicio del estudio a 51,1 ± 9,6 a los 12 meses, p < 0,0001); los demás ámbitos sexuales se mantuvieron estables. La función urinaria se mantuvo estable (media, 7,2 ± 6,3 al inicio del estudio y 5,4 ± 6,3 a los 12 meses, p = 0,08). La indicación quirúrgica se asoció significativamente con la función intestinal postoperatoria ( p = 0,0003). LIMITACIONES: El tamaño de la muestra es limitado; el seguimiento se limitó a 12 meses. CONCLUSIÓN: En esta cohorte prospectiva multicéntrica, la anastomosis ileoanal condujo a mejoras significativas en la función intestinal, la continencia, el interés sexual y la salud general, sin deterioro de las funciones urinarias u otras funciones sexuales. Estos hallazgos respaldan el papel de la anastomosis ileoanal en la restauración de la función y sirven de base para el asesoramiento preoperatorio y la toma de decisiones. (AI-generated translation )

3 November 2022 in Surgery
Verified
Journal Article
Closed access
JZJesse Zuckerman
Jesse Zuckerman
NCNatalie Coburn
Natalie Coburn
JCJeannie Callum
Jeannie Callum
AMAlyson L. Mahar
Alyson L. Mahar
YLYulia Lin
Yulia Lin
JHJulie Hallet
Julie Hallet